A new model of experimental autoimmune keratoconjunctivitis sicca (KCS) induced in Lewis rat by the autoantigen Klk1b22

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2245-2254

  Jiang, Guomin ^a   Ke, Yan ^a   Sun, Deming ^a   Li, Hao ^a   Ihnen, Mark ^a   Jumblatt, Marcia M ^a   Foulks, Gary ^a   Wang, Yali ^a   Bian, Yang ^a   Kaplan, Henry J ^a   Shao, Hui ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; KALLIKREIN; KALLIKREIN 1B22; LACRIMAL GLAND EXTRACT; SALIVARY GLAND EXTRACT; TISSUE EXTRACT; UNCLASSIFIED DRUG; AUTOANTIBODY; KALLIKREIN 1B22, MOUSE; RECOMBINANT PROTEIN;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA OPACITY; DISEASE SEVERITY; EYE DISEASE; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; KERATOCONJUNCTIVITIS SICCA; LACRIMAL DUCT; LACRIMAL FLUID; LACRIMAL GLAND; LEWIS RAT; LYMPHOBLAST; LYMPHOCYTIC INFILTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SALIVARY GLAND; SJOEGREN SYNDROME; SYMPTOM; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; AUTOIMMUNITY; BLEPHARITIS; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; KERATITIS; LACRIMAL APPARATUS; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; METABOLISM; MOUSE; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BLEPHARITIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOENZYME TECHNIQUES; KALLIKREINS; KERATITIS; KERATOCONJUNCTIVITIS SICCA; LACRIMAL APPARATUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SALIVARY GLANDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTES; TEARS;

EID: 65549086145     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1949     Document Type: Article

References (44)

1. Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjögren's syndrome. How strong is the evidence? (Review). Clin Dev Immunol. 2006;13:209-222.
2. Hansen A, Lipsky PE, Dorner T. Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol. 2005;17:558-565.
3. Soyfoo MS, Steinfeld S, Delporte C. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome. Oral Dis. 2007;13: 366-375.
4. Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol. 1992;263:E607-E614.
5. Ishimaru N, Yoneda T, Saegusa K, et al. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis. Am J Pathol. 2000;156:1557-1564.
6. Jonsson R, Tarkowski A, Backman K, Holmdahl R, Klareskog L. Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology. 1987;60:611-616.
7. Jonsson R, Tarkowski A, Backman K, Klareskog L. Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice. Clin Immunol Immunopathol. 1987;42:93-101.
8. Saegusa J, Kubota H. Sialadenitis in IQI/Jic mice: a new animal model of Sjögren's syndrome. J Vet Med Sci. 1997;59:897-903.
9. Tsubata R, Tsubata T, Hiai H, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjögren's syndrome. Eur J Immunol. 1996;26:2742-2748.
10. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature. 1989; 341:72-74.
11. Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190:1697-1710.
12. Saito I, Haruta K, Shimuta M, et al. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J Immunol. 1999;162:2488-2494.
13. Shen L, Zhang C, Wang T, et al. Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol. 2006;177:5676-5686.
14. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
15. Shim GJ, Warner M, Kim HJ, et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren's syndrome. Proc Natl Acad Sci U S A. 2004;101: 12628-12633.
16. Li H, Dai M, Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjögren's syndrome. Immunity. 2004;21:551-560.
17. Oak JS, Deane JA, Kharas MG, et al. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci U S A. 2006;103:16882-16887.
18. Hayashi Y, Hirokawa K. Immunopathology of experimental autoallergic sialadenitis in C3H/He mice. Clin Exp Immunol. 1989;75: 471-476.
19. Liu SH, Prendergast RA, Silverstein AM. Experimental autoimmune dacryoadenitis. I. Lacrimal gland disease in the rat. Invest Ophthalmol Vis Sci. 1987;28:270-275.
20. Liu SH, Zhou DH. Experimental autoimmune dacryoadenitis: purification and characterization of a lacrimal gland antigen. Invest Ophthalmol Vis Sci. 1992;33:2029-2036.
21. Nishimori I, Bratanova T, Toshkov I, et al. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol. 1995;154:4865-4873.
22. Fujihara T, Fujita H, Tsubota K, et al. Preferential localization of CD8 alpha E beta 7 T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol. 1999; 163:2226-2235.
23. Barabino S, Chen W, Dana MR. Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res. 2004;79:613-621.
24. Inoue K, Okugawa K, Kato S, Inoue Y, Oshika T, Amano S. Ocular factors relevant to keratoepitheliopathy in glaucoma patients with and without diabetes mellitus. Jpn J Ophthalmol. 2003;47:287-290.
25. Miyata K, Amano S, Sawa M, Nishida T. A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability. Arch Ophthalmol. 2003;121: 1537-1539.
26. Fox RI, Liu AY. Sjögren's syndrome in dermatology. Clin Dermatol. 2006;24:393-413.
27. Jabs DA, Prendergast RA. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. Invest Ophthalmol Vis Sci. 1988;29:1437-1443.
28. Jensen ON, Wilm M, Shevchenko A, Mann M. Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels. Methods Mol Biol. 1999;112:513-530.
29. Singh S, Powell DW, Rane MJ, et al. Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis. J Biol Chem. 2003;278: 36410-36417.
30. Lundwall A, Band V, Blaber M, et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol Chem. 2006;387:637-641.
31. Clements JA. The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr Rev. 1989; 10:393-419.
32. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988;6:49-83.
33. Bhoola K, Ramsaroop R, Plendl J, Cassim B, Dlamini Z, Naicker S. Kallikrein and kinin receptor expression in inflammation and cancer. Biol Chem. 2001;382:77-89.
34. Takada K, Takiguchi M, Konno A, Inaba M. Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjögren's syndrome. J Biol Chem. 2005;280:3982-3988.
35. Friberg B, Jonsson R, Linde A. Salivary kallikrein in Sjögren's syndrome. Clin Exp Rheumatol. 1988;6:135-138.
36. Hernandez CC, Donadi EA, Reis ML. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome. J Rheumatol. 1998;25:2381-2384.
37. Hosoi K, Tsunasawa S, Kurihara K, et al. Identification of mKl, a true tissue (glandular) kallikrein of mouse submandibular gland: tissue distribution and a comparison of kinin-releasing activity with other submandibular kallikreins. J Biochem (Tokyo). 1994;115: 137-143.
38. Kikkawa Y, Yamanaka N, Tada J, Kanamori N, Tsumura K, Hosoi K. Prorenin processing and restricted endoproteolysis by mouse tissue kallikrein family enzymes (mK1, mK9, mK13, and mK22). Biochim Biophys Acta (BBA.) - Protein Structure and Molecular Enzymology. 1998;1382:55-64.
39. Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol. 1969;102:117-122.
40. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest. 1975;55:1067-1073.
41. Yanagi K, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. Eur J Immunol. 1998;28:3336-3345.
42. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol. 1999;49:7-10.
43. Uddin M, Polley-Mandal M, Beg OU. Kallikrein-like prorenin-converting enzymes in inbred hypertensive mice. Biochemical and Biophysical Research Communications. 2003;304:724-728.
44. Takada K, Takiguchi M, Konno A, Inaba M. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjögren's syndrome. Rheumatology. 2004;43:858-862.